DK2202307T3 - Fremgangsmåde til fremstiling af et antistof - Google Patents

Fremgangsmåde til fremstiling af et antistof

Info

Publication number
DK2202307T3
DK2202307T3 DK08838661.0T DK08838661T DK2202307T3 DK 2202307 T3 DK2202307 T3 DK 2202307T3 DK 08838661 T DK08838661 T DK 08838661T DK 2202307 T3 DK2202307 T3 DK 2202307T3
Authority
DK
Denmark
Prior art keywords
antibody
producing
Prior art date
Application number
DK08838661.0T
Other languages
English (en)
Other versions
DK2202307T4 (da
Inventor
Yoshiki Yamada
Tatsuya Kiyasu
Kazuyuki Tabata
Akihiro Kuzumaki
Mai Yamashiro
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40567372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2202307(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of DK2202307T3 publication Critical patent/DK2202307T3/da
Application granted granted Critical
Publication of DK2202307T4 publication Critical patent/DK2202307T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
DK08838661.0T 2007-10-15 2008-10-14 Fremgangsmåde til fremstiling af et antistof DK2202307T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007267384 2007-10-15
JP2008103308 2008-04-11
PCT/JP2008/068588 WO2009051108A1 (ja) 2007-10-15 2008-10-14 抗体の製造方法

Publications (2)

Publication Number Publication Date
DK2202307T3 true DK2202307T3 (da) 2014-09-15
DK2202307T4 DK2202307T4 (da) 2021-10-04

Family

ID=40567372

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08838661.0T DK2202307T4 (da) 2007-10-15 2008-10-14 Fremgangsmåde til fremstiling af et antistof

Country Status (17)

Country Link
US (3) US9683027B2 (da)
EP (1) EP2202307B2 (da)
JP (4) JP4976502B2 (da)
KR (1) KR101558009B1 (da)
CN (3) CN106244651A (da)
AU (1) AU2008312937B2 (da)
BR (1) BRPI0818674B1 (da)
CA (1) CA2701338C (da)
DK (1) DK2202307T4 (da)
ES (1) ES2499391T5 (da)
IL (2) IL205051A (da)
MX (1) MX2010004007A (da)
PL (1) PL2202307T5 (da)
SG (1) SG185302A1 (da)
SI (1) SI2202307T2 (da)
TW (1) TWI463010B (da)
WO (1) WO2009051108A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2202307T2 (sl) * 2007-10-15 2021-11-30 Chugai Seiyaku Kabushiki Kaisha Postopek za proizvodnjo protitelesa
KR101860175B1 (ko) 2009-10-26 2018-05-21 에프. 호프만-라 로슈 아게 글리코실화된 면역글로불린의 제조 방법
KR101903208B1 (ko) * 2010-12-28 2018-10-01 추가이 세이야쿠 가부시키가이샤 동물 세포의 배양 방법
AR095348A1 (es) * 2013-03-15 2015-10-07 Genentech Inc Medios de cultivo celular y métodos de producción de anticuerpos
JP6563910B2 (ja) 2013-07-04 2019-08-21 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 血清サンプル中の抗薬物抗体を検出するための干渉抑制イムノアッセイ
US20190225694A1 (en) 2016-06-28 2019-07-25 Zaklady Farmaceutyczne Polpharma Sa Recombinant production of monoclonal antibodies
EP3541413A2 (en) 2016-11-21 2019-09-25 Polpharma Biologics S.A. Aqueous pharmaceutical formulations

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPS6459878A (en) 1987-08-31 1989-03-07 Matsushita Electric Ind Co Ltd Semiconductor laser protective circuit
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
CA2109602C (en) 1990-07-10 2002-10-01 Gregory P. Winter Methods for producing members of specific binding pairs
ES2108048T3 (es) 1990-08-29 1997-12-16 Genpharm Int Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
CA2090969C (en) † 1990-09-04 2001-08-21 Russell Arthur Brierley Production of insulin-like growth factor-1 in methylotrophic yeast cells
EP0628639B1 (en) 1991-04-25 1999-06-23 Chugai Seiyaku Kabushiki Kaisha Reconstituted human antibody against human interleukin 6 receptor
WO1993006213A1 (en) 1991-09-23 1993-04-01 Medical Research Council Production of chimeric antibodies - a combinatorial approach
WO1993011236A1 (en) 1991-12-02 1993-06-10 Medical Research Council Production of anti-self antibodies from antibody segment repertoires and displayed on phage
EP0746609A4 (en) 1991-12-17 1997-12-17 Genpharm Int NON-HUMAN TRANSGENIC ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES
EP0656941B1 (en) 1992-03-24 2005-06-01 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
WO1994002602A1 (en) 1992-07-24 1994-02-03 Cell Genesys, Inc. Generation of xenogeneic antibodies
AU6819494A (en) 1993-04-26 1994-11-21 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
GB9313509D0 (en) 1993-06-30 1993-08-11 Medical Res Council Chemisynthetic libraries
JPH09506508A (ja) 1993-12-03 1997-06-30 メディカル リサーチ カウンシル 組換え結合タンパク質およびペプチド
CA2194907A1 (en) 1994-07-13 1996-02-01 Kouji Matsushima Reshaped human antibody against human interleukin-8
US5561053A (en) 1994-08-05 1996-10-01 Genentech, Inc. Method for selecting high-expressing host cells
AU5632296A (en) 1995-04-27 1996-11-18 Abgenix, Inc. Human antibodies derived from immunized xenomice
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
AU8755798A (en) * 1997-04-04 1998-11-13 Biosite Diagnostics Incorporated Polyvalent and polyclonal libraries
US20020062010A1 (en) 1997-05-02 2002-05-23 Genentech, Inc. Method for making multispecific antibodies having heteromultimeric and common components
EP0979281B1 (en) 1997-05-02 2005-07-20 Genentech, Inc. A method for making multispecific antibodies having heteromultimeric and common components
US6171586B1 (en) * 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
WO2002079255A1 (en) † 2001-04-02 2002-10-10 Idec Pharmaceuticals Corporation RECOMBINANT ANTIBODIES COEXPRESSED WITH GnTIII
US6605176B2 (en) 2001-07-13 2003-08-12 Taiwan Semiconductor Manufacturing Co., Ltd. Aperture for linear control of vacuum chamber pressure
US20030157641A1 (en) * 2001-11-16 2003-08-21 Idec Pharmaceuticals Corporation Polycistronic expression of antibodies
MXPA04004634A (es) * 2001-11-16 2004-08-12 Idec Pharma Corp Expresion policistronica de anticuerpos.
WO2005005636A1 (ja) 2003-07-15 2005-01-20 Chugai Seiyaku Kabushiki Kaisha 形質転換細胞によるIｇMの産生とその定量方法
WO2005089285A2 (en) * 2004-03-15 2005-09-29 Biogen Idec Ma Inc. Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
EP2314317A3 (en) 2004-07-09 2011-06-29 Chugai Seiyaku Kabushiki Kaisha Anti-glypican 3 antibody
GB0425534D0 (en) * 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
JP2009508470A (ja) * 2005-07-21 2009-03-05 アボット・ラボラトリーズ Ｓｏｒｆ構築物並びにポリタンパク質、プロタンパク質及びタンパク質分解による方法を含む複数の遺伝子発現
SI2202307T2 (sl) * 2007-10-15 2021-11-30 Chugai Seiyaku Kabushiki Kaisha Postopek za proizvodnjo protitelesa

Also Published As

Publication number Publication date
EP2202307B1 (en) 2014-08-20
SG185302A1 (en) 2012-11-29
CN106244651A (zh) 2016-12-21
ES2499391T5 (es) 2021-12-22
IL205051A0 (en) 2010-11-30
US11136375B2 (en) 2021-10-05
CA2701338C (en) 2018-09-18
KR101558009B1 (ko) 2015-10-19
JPWO2009051108A1 (ja) 2011-03-03
JP6092304B2 (ja) 2017-03-08
KR20100074184A (ko) 2010-07-01
JP2012143246A (ja) 2012-08-02
EP2202307B2 (en) 2021-07-14
JP2017079794A (ja) 2017-05-18
PL2202307T5 (pl) 2021-10-04
US20100291627A1 (en) 2010-11-18
AU2008312937B2 (en) 2015-01-22
EP2202307A4 (en) 2012-01-25
IL240122B (en) 2019-02-28
BRPI0818674B1 (pt) 2023-01-17
IL205051A (en) 2015-09-24
US20170275351A1 (en) 2017-09-28
BRPI0818674A2 (pt) 2014-10-14
TW200934867A (en) 2009-08-16
WO2009051108A1 (ja) 2009-04-23
CN103540632A (zh) 2014-01-29
CA2701338A1 (en) 2009-04-23
JP6506786B2 (ja) 2019-04-24
DK2202307T4 (da) 2021-10-04
SI2202307T1 (sl) 2014-11-28
US9683027B2 (en) 2017-06-20
US20210300996A1 (en) 2021-09-30
PL2202307T3 (pl) 2015-02-27
MX2010004007A (es) 2010-06-15
CN101802192A (zh) 2010-08-11
AU2008312937A1 (en) 2009-04-23
EP2202307A1 (en) 2010-06-30
SI2202307T2 (sl) 2021-11-30
JP5788830B2 (ja) 2015-10-07
TWI463010B (zh) 2014-12-01
JP2015198663A (ja) 2015-11-12
JP4976502B2 (ja) 2012-07-18
ES2499391T3 (es) 2014-09-29
IL240122A0 (en) 2015-09-24

Similar Documents

Publication Publication Date Title
DK2054711T3 (da) Fremgangsmåde til fremstilling af mikroarrays
DK2044002T3 (da) Fremgangsmåde til fremstilling af 3-substituerede 2-amino-5-halobenzamider
DK3730045T3 (da) Fremgangsmåde til indføring af en analytsensor
DK2350128T3 (da) Fremgangsmåder til fremstilling af antistoffer fra plasmaceller
BRPI0814359A2 (pt) Método
BRPI0817226A2 (pt) Método
BRPI0817726A2 (pt) Método
BRPI0907532A2 (pt) Anticorpos anti-c5ar humanizados
DK3714788T3 (da) Fremgangsmåde til fremstilling af forbedrede analytsensorer
DK2029567T3 (da) Fremgangsmåde til frembringelse af benzopyran-2-ol-derivater
DK2531526T3 (da) Fremgangsmåde til opnåelse af antistoffer
DK1844662T3 (da) Metode til belægning af objekter
DK2451839T3 (da) Fremgangsmåde til produktion af variable domæner
DK2358661T3 (da) Fremgangsmåde til fremstilling af trans-4-amino-cyclohexyl-eddikesyreethylester-hcl
DK2126801T3 (da) Fremgangsmåde til udvælgelse af information
DK3106875T3 (da) Fremgangsmåde til detektering af cancer
DK2061746T3 (da) Fremgangsmåde til fremstilling af diestere
FI20075505A (fi) Menetelmä silmälasien valmistamiseksi
DK1976960T3 (da) Fremgangsmåde til fremstilling af biodiesel
DK2367783T3 (da) Fremgangsmåde til fremstilling af et isocyanat
DK2019118T3 (da) Fremgangsmåde til syntetisering af thymosiner
DK2076330T3 (da) Fremgangsmåde til fremstilling af katalysatorer
FI20065363A0 (fi) Erotusmenetelmä
DK2160225T3 (da) Fremgangsmåde til fremstilling af krystaller
DK3214083T3 (da) Fremgangsmåde til fremstilling af quinolonforbindelser